20035026

pubmed:Citation

3

Gap junctions are critical to maintaining synchronized impulse propagation and repolarization. Heterogeneous expression of the principal ventricular gap junction protein connexin43 (Cx43) is associated with action potential duration (APD) dispersion across the anterior ventricular wall. Little is known about Cx43 expression patterns and their disparate impact on regional electrophysiology throughout the heart. We aimed to determine whether the anterior and posterior regions of the heart are electrophysiologically distinct. Multisegment, high-resolution optical mapping was performed in canine wedge preparations harvested separately from the anterior left ventricle (aLV; n = 8) and posterior left ventricle (pLV; n = 8). Transmural APD dispersion was significantly greater on the aLV than the pLV (45 +/- 13 vs. 26 +/- 8.0 ms; P < 0.05). Conduction velocity dispersion was also significantly higher (P < 0.05) across the aLV (39 +/- 7%) than the pLV (16 +/- 3%). Carbenoxolone perfusion significantly enhanced APD and conduction velocity dispersion on the aLV (by 1.53-fold and 1.36-fold, respectively), but not the pLV (by 1.27-fold and 1.2-fold, respectively), and produced a 4.2-fold increase in susceptibility to inducible arrhythmias in the aLV. Confocal immunofluorescence microscopy revealed significantly (P < 0.05) greater transmural dispersion of Cx43 expression on the aLV (44 +/- 10%) compared with the pLV wall (8.3 +/- 0.7%), suggesting that regional expression of Cx43 expression patterns may account for regional electrophysiological differences. Computer simulations affirmed that localized uncoupling at the epicardial-midmyocardial interface is sufficient to produce APD gradients observed on the aLV. These data demonstrate that the aLV and pLV differ importantly with respect to their electrophysiological properties and Cx43 expression patterns. Furthermore, local underexpression of Cx43 is closely associated with transmural electrophysiological heterogeneity on the aLV. Therefore, regional and transmural heterogeneous Cx43 expression patterns may be an important mechanism underlying arrhythmia susceptibility, particularly in disease states where gap junction expression is altered.

http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-10028928, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-10318671, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-10688323, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-10775148, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-10948066, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-11073889, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-11158958, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-11386519, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-11454554, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-11454573, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-11470461, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-11889021, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-11934868, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-12181133, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-12933704, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-14613858, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-14704225, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-14715504, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-15205174, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-15705967, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-15863452, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-16037569, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-16686686, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-16979013, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-17562957, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-19452487, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-19560091, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-2036721, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-2678165, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-2805251, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-7514509, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-7859382, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-8394786, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-8431990, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-8589873, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-8930734, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-9349389, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-9351447, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-9495300, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-9742058, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-9799214, http://linkedlifedata.com/resource/pubmed/commentcorrection/20035026-9879451

http://linkedlifedata.com/resource/pubmed/journal/100901228

http://linkedlifedata.com/resource/pubmed/chemical/Connexin 43

Mar

pubmed-author:FickerEckhardE, pubmed-author:PoelzingStevenS, pubmed-author:RosenbaumDavid SDS, pubmed-author:StromMariaM, pubmed-author:WanXiaopingX

298

Y

2011-7-25

2010

The Heart and Vascular Research Center, and The Department Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44109-1998, USA.